JoS.A.Bank Clothiers Inc.announces that net income for the third quarter of fiscal year 2012 decreased 11.2%to$13.3 million as compared with net income of$15.0 million for the third quarter of fiscal year 2011.Diluted earnings per share for ...
Tags: net income, total sales, earnings
TRW Automotive Holdings (TRW) has reported sales of $3.69bn for the third quarter ended 28 September 2012, an increase of 1%, compared to $3.91bn for the same period of 2011. The company posted a gross profit of $414m for the third ...
Tags: TRW, gross profit, operating income, share repurchase program
(000 metric tonnes)9M'129M'11change Semi-finished products1,9662,599-24% Iron311368-15% Slabs1,0431,920-46% Square billets61231197% Finished products6,6227,126-7% Flat products4.4414,978-11% Long products1,9041,952-2% Rail ...
Tags: metal products, Metinvest, flat products
Saudi Arabia is pushing ahead with a major project to develop the world's fifth largest oilfield which will pump nearly 900,000 barrels per day of heavy crude and 90 million cubic feet per day of sour gas. State owned Saudi Aramco said ...
Tags: oilfield, Heavy crude oil, crude oil
EpiCept has reported a net loss of $1.13m, or $0.03 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.40m, or $0.08 per share, for the same period in 2011. Loss from operations for the third quarter of ...
Tags: Net Loss, merger partner, operating loss
USA - It's only a matter of weeks until PLASA Focus: Stamford 2012 shines a spotlight on the very latest entertainment technology products making their way to the tri-state Area. Now the third regional PLASA event to be held in North ...
Tags: DMX moving heads, Energy Saving, Platinum Beam, LED performance lighting
Galena Biopharma has reported a net loss of $6.26m, or $0.09 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.47m, or $0.09 per share, for the third quarter ended 30 September 2011. Operating loss for ...
Tags: Net Loss, operational and business development, patient enrollment
Sophiris Bio has reported a net loss of $5.62m, or $0.03 per share, for the third quarter ended 30 September 2012 compared to a net loss of $2.97m, or $0.02 per share, for the third quarter ended 30 September 2011. Expenses for third ...
Tags: Sophiris Bio, net loss, Q3 Net Loss, PRX302 clinical program
1. Crude steel output in Q3 2012 was 3.4 million tonnes (up 2% QoQ. 2. Finished steel output in Q3 2012 was 3.07 million tonnes (up 0.3% QoQ). 3. MMK Group’s total output of high value added (HVA) products in Q3 2012 was 1,276,000 ...
Tags: Crude steel output, steel output
For third-quarter 2012, , CA, USA has reported revenue of $20.8m, down 17.5% on $25.2m last quarter and down 26.5% on $28.3m a year ago. Gallium arsenide (GaAs) substrate revenue was $12.9m, down 13% on $14.9m last quarter and 31% on ...
Keryx Biopharmaceuticals has reported a net loss of $5.47m, or $0.08 per share, for the third quarter ended 30 September 2012 compared to a net loss of $10.25m, or $0.15 per share, for the third quarter ended 30 September 2011. Operating ...
Tags: Net Loss, Biopharmaceuticals, top-line data
Google has acquired retail coupon firm Incentive Targeting for an undisclosed sum. Google's Mike Dudas, a member of the team building Google's mobile commerce business, confirmed the news on Twitter. Further reading Google allows ...
Tags: Google, Incentive Targeting, retail coupon, Mike Dudas
Novavax has reported a net loss of $7.22m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss of $3.21m, or $0.03 per share, for the third quarter ended 30 September 2011. Revenue for third quarter of ...
Tags: Novavax, Wider Q3 Net Loss, net loss, clinical trials
For third-quarter 2012, Kopin Corp of Taunton, MA, USA, a supplier of III-V semiconductor products and microdisplays for mobile applications (including smartphones, tablet PCs, military thermal weapons sights and wearable computers), has ...
Tags: Kopin, Kopin Corp of Taunton, III-V semiconductor, microdisplay
Immunovaccine has reported a net loss of $1.7m for the third quarter ended 30 September 2012 compared to a net loss of $1.5m for the same quarter in 2011. According to the company the increased loss is due to the $155,000 increase in ...
Tags: Net Loss, therapeutic cancer vaccine, immune enhancement technology